FDA Inspection 1169414 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on May 4, 2022 in Saint Joseph, MO. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 4, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Saint Joseph, MO (United States)